By Drug Target Review2025-06-16T08:30:51
Shift Bioscience has announced new aging research, highlighting the discovery of SB000. This novel single-gene target reverses cellular aging without activating dangerous pluripotency pathways.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2024-02-08T11:07:39
Sponsored by Samplix ApS
2024-02-01T12:06:43
Sponsored by Leica Microsystems
2023-09-27T10:36:50
Sponsored by NanoTemper Technologies
2023-11-24T12:06:45
Sponsored by Quantum-Si
2023-09-27T13:56:39
Sponsored by Euretos
2024-05-07T13:11:19
Sponsored by BellBrook Labs
Site powered by Webvision Cloud